Hester Biosciences Q2 Results FY27: Net Profit Jumps 43.96%, Revenue Rs 97.91 Cr, PAT Rs 20.63 Cr
- November 5, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Hester Biosciences Q2 Results FY27 were declared on 5 November 2026. The Consolidated quarterly results show revenue of Rs 97.91 Cr against Rs 70.97 Cr a year earlier, which is YoY growth of 37.96%. Net profit rose 43.96% to Rs 20.63 Cr from Rs 14.33 Cr in the same quarter last year. The figures cover the July to September 2026 quarter.
Hester Biosciences Ltd (HESTERBIO) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. Revenue stood at Rs 97.91 Cr and net profit (PAT) at Rs 20.63 Cr on a Consolidated basis. The results date anchors the comparison, and these consolidated results in Hester Biosciences Q2 Results FY27 sit against the same quarter a year earlier.
This results analysis covers the financial highlights, business drivers, outlook and risks behind Hester Biosciences Q2 Results. Univest readers can start with the Financial Highlights table below, which sets the Consolidated quarter against the year-ago figures before the narrative breaks them down.
Click Here – Get Free Investment Predictions
Hester Biosciences Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 97.91 Cr | Rs 70.97 Cr | +37.96% YoY |
| Operating Profit | Rs 32.66 Cr | Rs 11.72 Cr | +178.67% YoY |
| Net Profit (PAT) | Rs 20.63 Cr | Rs 14.33 Cr | +43.96% YoY |
Source: company filing for Hester Biosciences Q2 Results FY27, 5 November 2026. Figures in Rs Crore, Consolidated basis.
Key Takeaways from Hester Biosciences Q2 Results: What Stands Out
- Revenue: Revenue grew 37.96% YoY to Rs 97.91 Cr from Rs 70.97 Cr, an increase of Rs 26.94 Cr over the comparison quarter.
- Net profit: Net profit rose 43.96% to Rs 20.63 Cr from Rs 14.33 Cr, a gain of Rs 6.30 Cr on the year-ago base.
- Operating Profit: Operating Profit rose 178.67% to Rs 32.66 Cr from Rs 11.72 Cr, the widest YoY growth among the three lines in Hester Biosciences Q2 Results FY27.
- Sequential view: Net profit was down 78.7% quarter on quarter from Rs 96.98 Cr, a sequential figure that the risks section covers.
- Next step: The performance analysis below explains how revenue, Operating Profit and net profit moved against the year-ago quarter.
Hester Biosciences Q2 Results FY27: Performance Analysis
Revenue, Operating Profit and net profit all rose YoY in the July to September 2026 quarter. Revenue reached Rs 97.91 Cr, up 37.96% from Rs 70.97 Cr, while net profit reached Rs 20.63 Cr, up 43.96% from Rs 14.33 Cr. This results analysis shows YoY growth in every line, with Operating Profit growing fastest.
In Hester Biosciences Q2 Results FY27, the Rs 26.94 Cr increase in revenue sat alongside a Rs 20.94 Cr increase in Operating Profit, which reached Rs 32.66 Cr from Rs 11.72 Cr. Net profit added Rs 6.30 Cr. The quarterly results therefore show Operating Profit growth of 178.67% against net profit growth of 43.96%.
For Hester Biosciences Q2 Results, the YoY comparison shows gains across all three lines, while the preceding-quarter comparison for net profit is lower. Investors following the next disclosure will compare each line against these same bases. The figures show what changed, and the disclosed drivers sit in the business factors, which is where the results analysis turns next.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue growth – The results analysis points first to revenue. Revenue grew 38.0% year on year to Rs 97.91 Cr in the latest quarter, giving Hester Biosciences Q2 Results FY27 a larger top line than the Rs 70.97 Cr of the comparison quarter.
Net profit growth – Net profit rose 44.0% year on year to Rs 20.63 Cr, against Rs 14.33 Cr a year earlier. This is the second factor in the quarterly results, and it grew faster than revenue over the same period.
Returns on capital – Return on equity was 17.05% in FY26 and return on capital employed was 16.21% in FY26. These FY26 return figures are part of the disclosed picture around the quarterly results.
FY27 Outlook After Hester Biosciences Q2 Results
FY27 full-year results will depend on the quarters still to be reported. This results analysis therefore rests on the reported numbers, and Hester Biosciences Q2 Results FY27 give net profit of Rs 20.63 Cr for the second quarter, one building block that each later quarter will add to.
With the second quarter on record, the next quarterly disclosure will show how revenue near Rs 97.91 Cr and net profit near Rs 20.63 Cr compare. Until then, Univest users can follow the 78.7% sequential decline in net profit, which leads directly into the risks that follow.
Key Risks to Watch After Hester Biosciences Q2 Results FY27
High Debt
Debt is high at 0.52 times total assets in FY26. Even with Hester Biosciences Q2 Results FY27 showing YoY growth in revenue and net profit, the FY26 debt level is a reminder to read profit growth against the balance sheet as well as against revenue.
Volatile Quarterly Profit
Quarterly net profit has been volatile, ranging from Rs 8.77 Cr to Rs 96.98 Cr over the last 5 quarters. A YoY growth of 43.96% therefore sits within a wide range, so each new quarter’s net profit is worth checking.
Sequential Net Profit Dip
Net profit was down 78.7% quarter on quarter from Rs 96.98 Cr. The YoY growth is large, but the quarter on quarter figure shows net profit well below the preceding quarter, so the sequential trend is worth following.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Hester Biosciences Q2 Results FY27 show revenue of Rs 97.91 Cr and net profit of Rs 20.63 Cr, up 37.96% and 43.96% YoY. The quarterly results show growth in every line, while the 78.7% sequential net profit dip and the FY26 debt level remain items to follow. For the full picture of Hester Biosciences Q2 Results as consolidated results, investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Hester Biosciences Q2 Results FY27
What are Hester Biosciences Q2 Results FY27?
Ans. Hester Biosciences Q2 Results FY27 are the Consolidated quarterly results for the July to September 2026 quarter, showing revenue of Rs 97.91 Cr. Alongside this, net profit was Rs 20.63 Cr, as the Quick Answer states.
What is the results date for Hester Biosciences Q2 Results FY27?
Ans. Hester Biosciences declared its Q2 FY27 results on 5 November 2026. This results date also marks the July to September 2026 quarter, so the figures in the introduction relate to that period.
What revenue was reported in Hester Biosciences Q2 Results FY27?
Ans. Hester Biosciences reported revenue of Rs 97.91 Cr in Q2 FY27. Compared with Rs 70.97 Cr a year earlier, this is an increase of Rs 26.94 Cr, as the Financial Highlights table shows.
What net profit was reported in Hester Biosciences Q2 Results FY27?
Ans. Hester Biosciences reported net profit of Rs 20.63 Cr in Q2 FY27. Compared with Rs 14.33 Cr in the same quarter last year, this is a rise of Rs 6.30 Cr, as the Performance Analysis explains.
How much YoY growth did revenue show in Hester Biosciences Q2 Results FY27?
Ans. Revenue showed YoY growth of 37.96% in Hester Biosciences Q2 Results FY27, rising from Rs 70.97 Cr to Rs 97.91 Cr. Alongside this, net profit grew 43.96%, as the Key Takeaways section shows.
Did net profit rise or fall in Hester Biosciences Q2 Results?
Ans. Net profit rose in Hester Biosciences Q2 Results, up 43.96% YoY from Rs 14.33 Cr to Rs 20.63 Cr. Compared with the preceding quarter, net profit was down 78.7%, as the Performance Analysis explains.
What was the Operating Profit in Hester Biosciences Q2 Results FY27?
Ans. Operating Profit in Hester Biosciences Q2 Results FY27 was Rs 32.66 Cr, up 178.67% YoY from Rs 11.72 Cr. This means it grew faster than revenue and net profit, as the Key Takeaways section explains.
Are Hester Biosciences Q2 Results consolidated results or standalone results?
Ans. Hester Biosciences Q2 Results are Consolidated results, as the company reported them on a Consolidated basis. So the revenue of Rs 97.91 Cr and net profit of Rs 20.63 Cr in the Financial Highlights table are Consolidated figures.
What business factors shaped Hester Biosciences Q2 Results FY27?
Ans. Hester Biosciences Q2 Results FY27 were shaped by revenue growth of 38.0%, net profit growth of 44.0% and FY26 return on equity of 17.05%. These points are set out in the Key Business Factors section.
What are the key risks after Hester Biosciences Q2 Results FY27?
Ans. The key risks after Hester Biosciences Q2 Results FY27 are FY26 debt of 0.52 times total assets, volatile quarterly net profit and a 78.7% sequential net profit dip. These are covered under Key Risks to Watch.
What is the outlook after Hester Biosciences Q2 Results?
Ans. After Hester Biosciences Q2 Results, FY27 full-year results will depend on the quarters still to be reported. Alongside this, net profit of Rs 20.63 Cr is one building block, as the Outlook section explains.
Where can I find the complete Hester Biosciences Q2 Results FY27 data?
Ans. The complete Hester Biosciences Q2 Results FY27 data sits in the Financial Highlights table, which lists revenue and net profit against the year-ago quarter. Univest also carries these quarterly results in its Screener and app.
